Replies to post #190405 on Biotech Values

[DewDiligence]

PFNX +7% on BARDA contract for anthrax vaccine:

http://finance.yahoo.com/news/pfenex-inc-awarded-hhs-contract-120000997.html

[DewDiligence]

DOW sells 600K shares of PFNX in secondary offering @$11.75—a 3% discount to yesterday’s close:

http://finance.yahoo.com/news/selling-shareholder-prices-secondary-offering-114500206.html

Curious that PR header does not mention PFNX.

After this sale, DOW will own about 2.2M shares of PFNX—approximately a 10% stake, down from a roughly 16% following PFNX’s Jul 2014 IPO (#msg-104638871). (DOW also sold some shares in an Apr 2015 secondary offering: #msg-113062102.)

PFNX was spun out from DOW in 2009.